AbbVie to buy Landos to expand pipeline of immunity-related illnesses

Landos Biopharma

25/03/2024 12:37

March 25 (Reuters) - AbbVie  ABBV.N  said on Monday it
would acquire drug developer Landos Biopharma  LABP.O  for up to
$212 million as the Humira-maker aims to expand its pipeline of
medicines to treat immune system-related illnesses.
    

 (Reporting by Leroy Leo in Bengaluru; Editing by Sriraj
Kalluvila)
 ((Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7;))